Does serum procalcitonin have a role in evaluating the severity of acute pancreatitis? A question revisited

World Journal of Surgery

Volumn 30, Issue 9, 2006, Pages 1713-1721

  Purkayastha, Sanjay ^a   Chow, Andre ^a   Athanasiou, Thanos ^a   Cambaroudis, Apostolos ^b   Panesar, Sukhmeet ^a   Kinross, James ^a   Tekkis, Paris ^a   Darzi, Ara ^a  

^a ST MARY S HOSPITAL   (United Kingdom)

^b ARISTOTLE UNIVERSITY MEDICAL SCHOOL   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

PROLACTIN;

ACUTE PANCREATITIS; AREA UNDER THE CURVE; CHEMICAL ANALYSIS; CLINICAL EXAMINATION; CONFERENCE PAPER; DIAGNOSTIC ACCURACY; DISEASE SEVERITY; HUMAN; PROLACTIN BLOOD LEVEL; RADIODIAGNOSIS; RECEIVER OPERATING CHARACTERISTIC; REGRESSION ANALYSIS; SCORING SYSTEM; SENSITIVITY AND SPECIFICITY; VALIDATION STUDY;

ACUTE DISEASE; AREA UNDER CURVE; CALCITONIN; HUMANS; PANCREATITIS; PROGNOSIS; PROTEIN PRECURSORS; ROC CURVE; SENSITIVITY AND SPECIFICITY; SEVERITY OF ILLNESS INDEX;

EID: 33748803909     PISSN: 03642313     EISSN: 14322323     Source Type: Journal    
DOI: 10.1007/s00268-006-0167-5     Document Type: Conference Paper

References (37)

1. Imrie CW. Acute pancreatitis: overview. Eur J Gastroenterol Hepatol 1997;9:103-105.
2. Department of Health. Primary Diagnosis-4-character 2004-2005. In NHS Health & Social Care Information Centre; 2005. http://www.hesonline.org.uk/ Ease/servlet/ContentServer?siteID=1937&categoryID-2.
3. Uhl W, Isenmann R, Curti G, et al. Influence of etiology on the course and outcome of acute pancreatitis. Pancreas 1996;13:335-343.
4. Papachristou GI, Whitcomb DC. Inflammatory markers of disease severity in acute pancreatitis. Clin Lab Med 2005;25:17-37.
5. Ranson JH, Rifkind KM, Roses DF, et al. Prognostic signs and the role of operative management in acute pancreatitis. Surg Gynecol Obstet 1974;139:69-81.
6. Ranson JH. Etiological and prognostic factors in human acute pancreatitis: a review. Am J Gastroenterol 1982;77:633-638.
7. Imrie CW, Benjamin IS, Ferguson JC, et al. A single-centre double-blind trial of Trasylol therapy in primary acute pancreatitis. Br J Surg 1978;65:337-341.
8. Bradley EL 3rd. A clinically based classification system for acute pancreatitis. Summary of the International Symposium on Acute Pancreatitis, Atlanta, GA, September 11-13, 1992. Arch Surg 1993;128:586-590.
9. Knaus WA, Draper EA, Wagner DP, et al. APACHE II: a severity of disease classification system. Crit Care Med 1985;13:818-829.
10. Balthazar EJ, Robinson DL, Megibow AJ, et al. Acute pancreatitis: value of CT in establishing prognosis. Radiology 1990;174:331-336.
11. Chatzicostas C, Roussomoustakaki M, Vardas E, et al. Balthazar computed tomography severity index is superior to Ranson criteria and APACHE II and III scoring systems in predicting acute pancreatitis outcome. J Clin Gastroenterol 2003;36:253-260.
12. Chatzicostas C, Roussomoustakaki M, Vlachonikolis IG, et al. Comparison of Ranson, APACHE II and APACHE III scoring systems in acute pancreatitis. Pancreas 2002;25:331-335.
13. Nijsten MW, Olinga P, The TH, et al. Procalcitonin behaves as a fast responding acute phase protein in vivo and in vitro. Crit Care Med 2000;28:458-461.
14. Oberhoffer M, Stonans I, Russwurm S, et al. Procalcitonin expression in human peripheral blood mononuclear cells and its modulation by lipopolysaccharides and sepsis-related cytokines in vitro. J Lab Clin Med 1999;134:49-55.
15. Simon L, Gauvin F, Amre DK, et al. Serum procalcitonin and C-reactive protein levels as markers of bacterial infection: a systematic review and meta-analysis. Clin Infect Dis 2004;39:206-217.
16. Shafiq N, Malhotra S, Bhasin DK, et al. Estimating the diagnostic accuracy of procalcitonin as a marker of the severity of acute pancreatitis: a meta-analytic approach. JOP J Pancreas 2005;6:231-237.
17. Bossuyt PM, Reitsma JB, Bruns DE, et al. Towards complete and accurate reporting of studies of diagnostic accuracy: the STARD initiative. BMJ 2003;326:41-44.
18. Moses LE, Shapiro D, Littenberg B. Combining independent studies of a diagnostic test into a summary ROC curve: data-analytic approaches and some additional considerations. Stat Med 1993;12:1293-1316.
19. Walter SD. Properties of the summary receiver operating characteristic (SROC) curve for diagnostic test data. Stat Med 2002;21:1237-1256.
20. Jaeschke R, Guyatt GH, Sackett DL. Users' guides to the medical literature. III. How to use an article about a diagnostic test. B. What are the results and will they help me in caring for my patients? The Evidence-Based Medicine Working Group. JAMA 1994;271:703-707.
21. Jaeschke R, Guyatt G, Sackett DL. Users' guides to the medical literature. III. How to use an article about a diagnostic test. A. Are the results of the study valid? Evidence-Based Medicine Working Group. JAMA 1994;271:389-391.
22. Irwig L, Tosteson AN, Gatsonis C, et al. Guidelines for meta-analyses evaluating diagnostic tests. Ann Intern Med 1994;120:667-676.
23. Frasquet J, Saez J, Trigo C, et al. Early measurement of procalcitonin does not predict severity in patients with acute pancreatitis. Br J Surg 2003;90:1129-1130.
24. Kylanpaa-Back ML, Takala A, Kemppainen E, et al. Procalcitonin strip test in the early detection of severe acute pancreatitis. Br J Surg 2001;88:2222-2227.
25. Kylanpaa-Back ML, Takala A, Kemppainen EA, et al. Procalcitonin, soluble interleukin-2 receptor, and soluble E-selectin in predicting the severity of acute pancreatitis. Crit Care Med 2001;29:63-69.
26. Mandi Y, Farkas G, Takacs T, et al. Diagnostic relevance of procalcitonin, IL-6, and sICAM-1 in the prediction of infected necrosis in acute pancreatitis. Int J Pancreatol 2000;28:41-49.
27. Melzi D'Eril GV, Merlini G, Finazzi S, et al. Procalcitonin is not a reliable marker for the assessment of severity in acute pancreatitis without infectious complications. Clin Chem 2000;46:428-430.
28. Muller CA, Uhl W, Printzen G, et al. Role of procalcitonin and granulocyte colony stimulating factor in the early prediction of infected necrosis in severe acute pancreatitis. Gut 2000;46:233-238.
29. Olah A, Belagyi T, Issekutz A, et al. Value of procalcitonin quick test in the differentiation between sterile and infected forms of acute pancreatitis. Hepatogastroenterology 2005;52:243-245.
30. Pezzilli R, Melzi d'Eril GV, Morselli-Labate AM, et al. Serum amyloid A, procalcitonin, and C-reactive protein in early assessment of severity of acute pancreatitis. Dig Dis Sci 2000;45:1072-1078.
31. Pindak D, Parrak V, Pechan J, et al. The clinical value of the procalcitonin in prediction of severity and outcome in acute pancreatitis. Hepatogastroenterology 2003;50:(Suppl 2) ccviii-ccix.
32. Rau B, Steinbach G, Gansauge F, et al. The potential role of procalcitonin and interleukin 8 in the prediction of infected necrosis in acute pancreatitis. Gut 1997;41:832-840.
33. Riche FC, Cholley BP, Laisne MJ, et al. Inflammatory cytokines, C reactive protein, and procalcitonin as early predictors of necrosis infection in acute necrotizing pancreatitis. Surgery 2003;133:257-262.
34. Yonetci N, Sungurtekin U, Oruc N, et al. Is procalcitonin a reliable marker for the diagnosis of infected pancreatic necrosis? Aust N Z J Surg 2004;74:591-595.
35. Ammori BJ, Becker KL, Kite P, et al. Calcitonin precursors: early markers of gut barrier dysfunction in patients with acute pancreatitis. Pancreas 2003;27:239-243.
36. Begg CB, McNeil BJ. Assessment of radiologic tests: control of bias and other design considerations. Radiology 1988;167:565-569.
37. Wilson C, Heads A, Shenkin A, et al. C-reactive protein, antiproteases and complement factors as objective markers of severity in acute pancreatitis. Br J Surg 1989;76:177-181.